Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-09-21 Sale |
2023-09-21 1:15 pm |
Paratek Pharmaceuticals Inc. | PRTK | Loh Evan CEO |
1,327,981 | $0 | $0 | 0 (Direct) |
View |
| 2023-08-09 Sale |
2023-08-10 8:26 pm |
Paratek Pharmaceuticals Inc. | PRTK | Loh Evan CEO |
48,967 | $2.2 | $107,727 | 1,327,981 (Direct) |
View |
| 2022-12-21 Sale |
2022-12-22 4:44 pm |
Paratek Pharmaceuticals Inc. | PRTK | Loh Evan CEO |
23,489 | $1.99 | $46,743 | 1,208,198 (Direct) |
View |
| 2022-12-12 Sale |
2022-12-14 8:08 pm |
Paratek Pharmaceuticals Inc. | PRTK | Loh Evan CEO |
99,750 | $1.9676 | $196,267 | 1,179,187 (Direct) |
View |
| 2022-10-28 Sale |
2022-11-01 7:58 pm |
Paratek Pharmaceuticals Inc. | PRTK | Loh Evan CEO |
8,805 | $3.47 | $30,553 | 1,278,937 (Direct) |
View |
| 2022-08-09 Sale |
2022-08-10 9:06 pm |
Paratek Pharmaceuticals Inc. | PRTK | Loh Evan CEO |
44,519 | $2.66 | $118,421 | 1,257,742 (Direct) |
View |
| 2021-12-13 Sale |
2021-12-15 8:45 pm |
Paratek Pharmaceuticals Inc. | PRTK | Loh Evan CEO |
87,076 | $4.3215 | $376,295 | 913,284 (Direct) |
View |
| 2021-08-17 Sale |
2021-08-18 7:29 pm |
Paratek Pharmaceuticals Inc. | PRTK | Loh Evan CEO |
33,931 | $5.12 | $173,727 | 1,000,360 (Direct) |
View |
| 2021-06-04 Sale |
2021-06-08 7:25 pm |
Paratek Pharmaceuticals Inc. | PRTK | Loh Evan CEO |
36,654 | $9.7 | $355,544 | 959,291 (Direct) |
View |
| 2021-03-15 Sale |
2021-03-15 7:30 pm |
Eiger BioPharmaceuticals Inc. | EIGR | Loh Evan Director |
2,000 | $10.14 | $20,280 | 18,000 (Direct) |
View |
| 2020-12-11 Sale |
2020-12-15 7:56 pm |
Paratek Pharmaceuticals Inc. | PRTK | Loh Evan CEO |
45,000 | $6.8091 | $306,410 | 600,559 (Direct) |
View |
| 2020-11-13 Sale |
2020-11-16 6:36 pm |
Paratek Pharmaceuticals Inc. | PRTK | Loh Evan CEO |
20,928 | $5.93 | $124,103 | 645,559 (Direct) |
View |
| 2020-05-12 Sale |
2020-05-14 6:27 pm |
Paratek Pharmaceuticals Inc. | PRTK | Loh Evan CEO |
9,595 | $4.75 | $45,576 | 552,008 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-08-08 Option Award |
2023-08-10 8:26 pm |
N/A N/A |
Paratek Pharmaceuticals Inc. | PRTK | Loh Evan CEO |
168,750 | $0 | 1,327,981 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 8:50 pm |
N/A 2033-02-28 |
Eiger BioPharmaceuticals Inc. | EIGR | Loh Evan Director |
28,000 | $0 | 28,000 (Direct) |
View |
| 2022-12-20 Option Award |
2022-12-22 4:44 pm |
N/A N/A |
Paratek Pharmaceuticals Inc. | PRTK | Loh Evan CEO |
52,500 | $0 | 1,208,198 (Direct) |
View |
| 2022-10-25 Option Award |
2022-10-27 7:06 pm |
N/A N/A |
Paratek Pharmaceuticals Inc. | PRTK | Loh Evan CEO |
30,000 | $0 | 1,287,742 (Direct) |
View |
| 2022-08-08 Option Award |
2022-08-10 9:06 pm |
N/A N/A |
Paratek Pharmaceuticals Inc. | PRTK | Loh Evan CEO |
152,727 | $0 | 1,257,742 (Direct) |
View |
| 2022-03-15 Option Award |
2022-03-23 8:41 pm |
N/A N/A |
Paratek Pharmaceuticals Inc. | PRTK | Loh Evan CEO |
236,250 | $0 | 1,149,534 (Direct) |
View |
| 2022-03-11 Option Award |
2022-03-11 9:06 pm |
N/A 2032-03-10 |
Eiger BioPharmaceuticals Inc. | EIGR | Loh Evan Director |
18,000 | $0 | 26,000 (Direct) |
View |
| 2021-08-16 Option Award |
2021-08-18 7:29 pm |
N/A N/A |
Paratek Pharmaceuticals Inc. | PRTK | Loh Evan CEO |
75,000 | $0 | 1,000,360 (Direct) |
View |
| 2021-05-27 Option Award |
2021-06-08 7:25 pm |
N/A N/A |
Paratek Pharmaceuticals Inc. | PRTK | Loh Evan CEO |
91,636 | $0 | 959,291 (Direct) |
View |
| 2021-03-30 Option Award |
2021-04-01 6:43 pm |
N/A N/A |
Paratek Pharmaceuticals Inc. | PRTK | Loh Evan CEO |
303,750 | $0 | 904,309 (Direct) |
View |
| 2021-03-12 Option Award |
2021-03-15 7:30 pm |
N/A 2031-03-11 |
Eiger BioPharmaceuticals Inc. | EIGR | Loh Evan Director |
15,000 | $0 | 18,000 (Direct) |
View |
| 2021-02-03 Option Award |
2021-02-05 9:01 pm |
2022-02-03 2031-02-03 |
WINDTREE THERAPEUTICS INC | WINT | Loh Evan Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2020-11-12 Option Award |
2020-11-16 6:36 pm |
N/A N/A |
Paratek Pharmaceuticals Inc. | PRTK | Loh Evan CEO |
75,000 | $0 | 645,559 (Direct) |
View |
| 2020-10-29 Exercise |
2020-11-02 4:50 pm |
N/A 2024-06-28 |
Paratek Pharmaceuticals Inc. | PRTK | Loh Evan CEO |
39,479 | $0 | 591,487 (Direct) |
View |
| 2020-10-29 Exercise |
2020-11-02 4:50 pm |
N/A N/A |
Paratek Pharmaceuticals Inc. | PRTK | Loh Evan CEO |
39,479 | $4.3 | 591,487 (Direct) |
View |